CSIR and Aurobindo Pharma to collaborate for COVID-19 vaccine development
DBT is also supporting Aurobindo Pharma’s COVID-19 vaccine development through its wholly-owned US subsidiary Auro Vaccines, under…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Auro Vaccines
Aurobindo Pharma expects Phase I and II trials of COVID-19 vaccine by end of 2020
The company's viral vaccine manufacturing capacity in India would be undertaken in two phases, the first phase would be ready by…
Aurobindo Pharma joins COVID-19 vaccine hunt
The company’s vaccine candidate has been shortlisted for BIRAC funding, will launch final product by the end of 2022